1. Home
  2. DX vs ATRC Comparison

DX vs ATRC Comparison

Compare DX & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynex Capital Inc.

DX

Dynex Capital Inc.

HOLD

Current Price

$13.88

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$40.33

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DX
ATRC
Founded
1987
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
DX
ATRC
Price
$13.88
$40.33
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$13.83
$52.22
AVG Volume (30 Days)
4.2M
530.6K
Earning Date
01-26-2026
02-11-2026
Dividend Yield
14.62%
N/A
EPS Growth
35.65
N/A
EPS
1.66
N/A
Revenue
$230,447,000.00
$518,304,999.00
Revenue This Year
N/A
$16.90
Revenue Next Year
$134.14
$12.29
P/E Ratio
$8.41
N/A
Revenue Growth
87.09
15.80
52 Week Low
$10.79
$28.29
52 Week High
$14.52
$43.11

Technical Indicators

Market Signals
Indicator
DX
ATRC
Relative Strength Index (RSI) 56.55 58.53
Support Level $13.81 $40.11
Resistance Level $13.98 $41.92
Average True Range (ATR) 0.18 1.23
MACD 0.00 -0.14
Stochastic Oscillator 69.83 44.02

Price Performance

Historical Comparison
DX
ATRC

About DX Dynex Capital Inc.

Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: